New Celiac Disease Drugs Get a Bold ANB033 Result
New celiac disease drugs: First Tracks says ANB033 protected the gut in a 32-patient trial. See the 2027 roadmap, the risks and what is unknown.
Tag: ANB033 clinical trial
Read More
New celiac disease drugs: First Tracks says ANB033 protected the gut in a 32-patient trial. See the 2027 roadmap, the risks and what is unknown.